157 related articles for article (PubMed ID: 3147901)
1. Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man.
Schjoldager BT; Baldissera FG; Mortensen PE; Holst JJ; Christiansen J
Eur J Clin Invest; 1988 Oct; 18(5):499-503. PubMed ID: 3147901
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of the C-terminal octapeptide of oxyntomodulin on pentagastrin-stimulated gastric acid secretion in man.
Veyrac M; Ribard D; Daures JP; Mion H; Lequellec A; Martinez J; Bataille D; Michel H
Scand J Gastroenterol; 1989 Dec; 24(10):1238-42. PubMed ID: 2690315
[TBL] [Abstract][Full Text] [Related]
3. Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs.
Baldissera FG; Holst JJ; Knuhtsen S; Hilsted L; Nielsen OV
Regul Pept; 1988 May; 21(1-2):151-66. PubMed ID: 2839871
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.
Schjoldager B; Mortensen PE; Myhre J; Christiansen J; Holst JJ
Dig Dis Sci; 1989 Sep; 34(9):1411-9. PubMed ID: 2670487
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl oxyntomodulin30-37: pharmacokinetics and activity on gastric acid secretion.
Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Rolland M; Bataille D
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):57-63. PubMed ID: 1538791
[TBL] [Abstract][Full Text] [Related]
6. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.
Jarrousse C; Audousset-Puech MP; Dubrasquet M; Niel H; Martinez J; Bataille D
FEBS Lett; 1985 Aug; 188(1):81-4. PubMed ID: 4018272
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
Dubrasquet M; Bataille D; Gespach C
Biosci Rep; 1982 Jun; 2(6):391-5. PubMed ID: 6125221
[No Abstract] [Full Text] [Related]
8. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.
Schjoldager BT; Mortensen PE; Christiansen J; Orskov C; Holst JJ
Dig Dis Sci; 1989 May; 34(5):703-8. PubMed ID: 2714145
[TBL] [Abstract][Full Text] [Related]
9. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion.
Jarrousse C; Niel H; Audousset-Puech MP; Martinez J; Bataille D
Peptides; 1986; 7 Suppl 1():253-6. PubMed ID: 3748850
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin enhances the inhibitory effect of oxyntomodulin and its C-terminal octapeptide on acid secretion.
Dubrasquet JM; Audousset-Puech MP; Martinez J; Bataille D
Peptides; 1986; 7 Suppl 1():257-9. PubMed ID: 2875447
[TBL] [Abstract][Full Text] [Related]
11. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats.
Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR
Digestion; 1985; 32(2):124-7. PubMed ID: 3899816
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
Bado A; Cloarec D; Moizo L; Laigneau JP; Bataille D; Lewin MJ
Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
[TBL] [Abstract][Full Text] [Related]
13. Activity of oxyntomodulin on gastric acid secretion induced by histamine or a meal in the rat.
Jarrousse C; Carles-Bonnet C; Niel H; Bataille D
Peptides; 1994; 15(8):1415-20. PubMed ID: 7700845
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat.
Jarrousse C; Carles-Bonnet C; Niel H; Sabatier R; Audousset-Puech MP; Blache P; Kervran A; Martinez J; Bataille D
Am J Physiol; 1993 May; 264(5 Pt 1):G816-23. PubMed ID: 8498507
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of pentagastrin-stimulated gastric acid secretion by intraileal administration of bile and elevation of plasma concentrations of gut glucagon-like immunoreactivity in anesthetized dogs.
Namba M; Matsuyama T; Itoh H; Imai Y; Horie H; Tarui S
Regul Pept; 1986 Sep; 15(2):121-8. PubMed ID: 3786834
[TBL] [Abstract][Full Text] [Related]
16. A pure enteroglucagon, oxyntomodulin (glucagon 37), stimulates insulin release in perfused rat pancreas.
Jarrousse C; Bataille D; Jeanrenaud B
Endocrinology; 1984 Jul; 115(1):102-5. PubMed ID: 6376068
[TBL] [Abstract][Full Text] [Related]
17. Infusion of a novel peptide, calcitonin gene-related peptide (CGRP) in man. Pharmacokinetics and effects on gastric acid secretion and on gastrointestinal hormones.
Kraenzlin ME; Ch'ng JL; Mulderry PK; Ghatei MA; Bloom SR
Regul Pept; 1985 Mar; 10(2-3):189-97. PubMed ID: 3922013
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
Digestion; 1992; 52(3-4):214-21. PubMed ID: 1459356
[TBL] [Abstract][Full Text] [Related]
19. Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat.
Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Bataille D
Eur J Pharmacol; 1991 Oct; 203(2):245-52. PubMed ID: 1800120
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man.
Wettergren A; Maina P; Boesby S; Holst JJ
Scand J Gastroenterol; 1997 Jun; 32(6):552-5. PubMed ID: 9200286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
